Trump administration passed on Pfizer Offer for more Vaccine supply, prompting shortage fears.
“According to The New York Times report, The Trump administration passed on an opportunity to buy more of Pfizer’s coronavirus vaccine over the summer, meaning the company may not be able to deliver additional doses beyond what’s already contracted until next summer due to commitments to other countries.”
“In July, the US government agreed to a deal with Pfizer and its German partner BioNTech to buy an initial tranche of 100 million doses of the vaccine for $1.95 billion. The treatment requires two injections, so that’s enough to vaccinate 50 million Americans, only a fraction of the total population. The deal contained the option to buy more doses,” Yahoomail reports.
“We are confident that we will have 100 million doses of Pfizer’s vaccine as agreed to in our contract, and beyond that, we have five other vaccine candidates,” a spokesperson for the Department of Health and Human Services told the Times.”